Pmv Pharmaceuticals earnings were -$58.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PMVP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$23.0M, up 19.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PMVP reported annual earnings of -$58.7M, with -14.9% growth. The next PMVP earnings date is May 7, 2025.
Pmv Pharmaceuticals Earnings Reports & History FAQ
What were Pmv Pharmaceuticals's earnings last quarter?
On PMVP's earnings call on Invalid Date, Pmv Pharmaceuticals (NASDAQ: PMVP) reported Q4 2024 earnings per share (EPS) of -$0.45, up 45.16% year over year. Total PMVP earnings for the quarter were -$23.00 million. In the same quarter last year, Pmv Pharmaceuticals's earnings per share (EPS) was -$0.31.
The next PMVP earnings date is Invalid Date. Add PMVP to your watchlist to be reminded of Pmv Pharmaceuticals's next earnings date.
What was PMVP's earnings growth in the past year?
As of Pmv Pharmaceuticals's earnings date in Invalid Date, Pmv Pharmaceuticals's earnings has grown year over year. PMVP earnings in the past year totalled -$58.71 million.
Is Pmv Pharmaceuticals profitable or losing money?
As of the last Pmv Pharmaceuticals earnings report, Pmv Pharmaceuticals is currently losing money. Pmv Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$58.71 million, a 14.87% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.